HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Clarins Gentle Care Deodorant Intro Leverages Skin Care Heritage

This article was originally published in The Rose Sheet

Executive Summary

Clarins is applying its skin care heritage and experience with botanical ingredients to launch a new line of Gentle Care deodorants

You may also be interested in...



Clarins Multi-Active Day Cream Reformulated With New Plant Extract

Clarins Multi-Active Day Cream Protection Plus, bowing in mid-January, incorporates plant extract mourera fluviatilis to offer enhanced skin protection and line prevention.

Clarins

Le Rouge lipstick, debuting Aug. 1, will replace bulk of Clarins' existing lipstick inventory to become preeminent lipstick, Clarins says. French skin care firm "is perfectly positioned to take a giant leap into the color category," company states, adding lipstick is key to succeeding in color. Le Rouge will be available in 36 shades, divided into "six mood-inspired harmonies": Emotion, Illusion, Passion Inspiration, Fusion and Sensation, ranging in shades from pinks to neutrals, reds, coppers and browns. Lipsticks will be housed in red metallic package with gold trim, which will be used for all future Clarins color cosmetics. Le Rouge lipsticks will retail for $18.50 each

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
UsernamePublicRestriction

Register

RS009997

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel